Do Transdermal Administration of α 1 - and α 2 -Adrenergic Receptor Antagonists Modulate Sweating in Exercising Young Females in the Heat?
Skin Pharmacology and Physiology · 2025
DOI: 10.1159/000546961 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Skin Pharmacology and Physiology, 2025. Verfasst von Lu Meng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan, mlu828865@gmail.com. Hauptthemen laut MEDLINE: Sweating, Exercise, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-2 Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Introduction
Adrenergic modulation of sweating remains equivocal in females. We investigated whether α1- and α2-adrenergic receptors can modulate sweating during active heat stress in healthy female participants.
Methods
Thirty young adults (15 females) cycled at 50% peak oxygen uptake for 30 min at 32°C and 40% relative humidity. Sweat rates (ventilated capsule technique) on both forearms were assessed following pretreatment with terazosin (α1-adrenergic receptor antagonist), rauwolscine (α2 antagonist), or control (NaCl) using transdermal iontophoresis procedure. The efficacy of α1 blockade was confirmed postexercise with phenylephrine (α1-adrenergic agonist)-induced sweating, while α2 antagonist efficacy was verified in a separate follow-up study assessing clonidine (α2 agonist)-induced cutaneous vasoconstriction.
Results
Participants sweated by 0.32 ± 0.13 and 0.54 ± 0.26 mg∙cm−2∙min−1 at the end of exercise for females and males, respectively. Neither terazosin nor rauwolscine affected sweating during exercise in males (p ≥ 0.125, interaction and treatment effect) or females (p ≥ 0.277) as compared to control sites. However, the reduction in sweat rate at the terazosin-treated site was negatively correlated with sweat rate at control sites in both sexes (all p ≤ 0.050, r ≤ −0.514), while no such correlation was observed for rauwolscine. Successful α1-blockade was confirmed by attenuated phenylephrine-induced sweating during postexercise (p ≤ 0.025). Rauwolscine effectively abolished clonidine-induced cutaneous vasoconstriction in a follow-up study, verifying successful transdermal delivery.
Conclusion
The α1- and α2-adrenergic receptors do not alter sweating during moderate-intensity exercise in males and females, at least among individuals with relatively low sweat production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan, mlu828865@gmail.com.
- Laboratory for Exercise and Environmental Physiology, Faculty of Education, Niigata University, Niigata, Japan.
- College of Physical Education, Hubei Normal University, Huangshi, China.
Zitieren
APA
Meng, L., Wang, H., Otsuka, J., Okamoto, Y., Yokoyama, S., Oshima, S., Kato, H., Lei, T. H., & Amano, T. (2025). Do Transdermal Administration of α 1 - and α 2 -Adrenergic Receptor Antagonists Modulate Sweating in Exercising Young Females in the Heat?. Skin Pharmacology and Physiology. https://doi.org/10.1159/000546961
Vancouver
Meng L, Wang H, Otsuka J, Okamoto Y, Yokoyama S, Oshima S, et al. Do Transdermal Administration of α 1 - and α 2 -Adrenergic Receptor Antagonists Modulate Sweating in Exercising Young Females in the Heat?. Skin Pharmacology and Physiology. 2025. doi:10.1159/000546961
BibTeX
@article{Meng2025,
author = {Meng, Lu and Wang, Hui and Otsuka, Junto and Okamoto, Yumi and Yokoyama, Shotaro and Oshima, Shoma and Kato, Hanano and Lei, Tze-Huan and Amano, Tatsuro},
title = {Do Transdermal Administration of α 1 - and α 2 -Adrenergic Receptor Antagonists Modulate Sweating in Exercising Young Females in the Heat?},
journal = {Skin Pharmacology and Physiology},
year = {2025},
doi = {10.1159/000546961}
}
EUVIMED